Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

Iloperidone: a new option for the treatment of schizophrenia

Author: Cutler, Andrew J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 12, December 2009 , pp. 1727-1741(15)

Publisher: Expert Reviews

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

Authors: Bushe, C. J.; Bradley, A. J.; Doshi, S.; Karagianis, J.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1743-1761(19)

Publisher: Blackwell Publishing

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Author: Hashimoto, Kenji

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 470-474(5)

Publisher: Bentham Science Publishers

Sudden death in patients receiving drugs tending to prolong the QT interval

Authors: Jolly, Kate; Gammage, Michael D.; Cheng, Kar Keung; Bradburn, Peter; Banting, Miriam V.; Langman, Michael J. S.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 743-751(9)

Publisher: Blackwell Publishing

Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China

Authors: Yang, Li; Li, Ming; Tao, Li-bo; Zhang, Mingliang; Nicholl, M. Deborah; Dong, Peng

Source: Value in Health, Volume 12, Supplement 3, November/December 2009 , pp. S66-S69(1)

Publisher: Blackwell Publishing

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

Authors: Aubry, Jean-Michel; Schwald, Michèle; Ballmann, Eladia; Karege, Félicien

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 419-429(11)

Publisher: Springer

Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study

Authors: De la Gándara, Jesús; San Molina, Luis; Rubio, Gabriel; Rodriguez-Morales, Alexander; Hidalgo Borrajo, Rebeca; Burón, José Antonio

Source: Expert Review of Neurotherapeutics, Volume 9, Number 10, October 2009 , pp. 1463-1474(12)

Publisher: Expert Reviews

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study

Authors: Pouwels, S.; Staa, T.; Egberts, A.; Leufkens, H.; Cooper, C.; Vries, F.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1499-1506(8)

Publisher: Springer

Aggressive Behaviour in Adults with Intellectual Disability: Defining the Role of Drug Treatment

Authors: Oliver-Africano, Patricia; Murphy, Declan; Tyrer, Peter

Source: CNS Drugs, Volume 23, Number 11, 1 November 2009 , pp. 903-913(11)

Publisher: Adis International

Effectiveness of Safety Warnings in Atypical Antipsychotic Drugs: An Interrupted Time-Series Analysis in Spain

Authors: Sanfélix-Gimeno, Gabriel; Cervera-Casino, Pedro; Peiró, Salvador; López-Valcarcel, Beatriz González; Blázquez, Amparo; Barbera, Teresa

Source: Drug Safety, Volume 32, Number 11, 1 November 2009 , pp. 1075-1087(13)

Publisher: Adis International

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

Authors: Samtani, Mahesh N.; Vermeulen, An; Stuyckens, Kim

Source: Clinical Pharmacokinetics, Volume 48, Number 9, 1 September 2009 , pp. 585-600(16)

Publisher: Adis International

Structure-based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor

Authors: Williams, Britney; Dwyer, Donard S.

Source: Journal of Neurochemistry, Volume 110, Number 6, September 2009 , pp. 1876-1884(9)

Publisher: Blackwell Publishing

Antipsychotic Drugs for First-Episode Schizophrenia: A Comparative Review

Authors: Salimi, Kayvon; Jarskog, L. Fredrik; Lieberman, Jeffrey A.

Source: CNS Drugs, Volume 23, Number 10, 1 October 2009 , pp. 837-855(19)

Publisher: Adis International

Iloperidone: In Schizophrenia

Author: Scott, Lesley J.

Source: CNS Drugs, Volume 23, Number 10, 1 October 2009 , pp. 867-880(14)

Publisher: Adis International

Aripiprazole: Dose-Response Relationship in Schizophrenia and Schizoaffective Disorder

Authors: Mace, Shubhra; Taylor, David

Source: CNS Drugs, Volume 23, Number 9, 1 September 2009 , pp. 773-780(8)

Publisher: Adis International

Atypical antipsychotic (clozapine) self-poisoning in late pregnancy presenting with absent fetal heart rate variability without acidosis and delayed peristalsis in the newborn baby: A case report

Authors: NOVIKOVA, N.; CHITNIS, M.; LINDER, V.; HOFMEYR, G. J.

Source: Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 49, Number 4, August 2009 , pp. 442-444(3)

Publisher: Blackwell Publishing

The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? A Systematic Review

Authors: Smieskova, R.; Fusar-Poli, P.; Allen, P.; Bendfeldt, K.; Stieglitz, R. D.; Drewe, J.; Radue, E. W.; McGuire, P. K.; Riecher-Rossler, A.; Borgwardt, S. J.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2535-2549(15)

Publisher: Bentham Science Publishers

What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?

Authors: Korostenskaja, M.; Kahkonen, S.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2573-2593(21)

Publisher: Bentham Science Publishers

Recent progress in the pharmacotherapy of bipolar disorder

Authors: Mitchell, Philip B; Loo, Colleen K; Breakspear, Michael

Source: Future Neurology, Volume 4, Number 4, July 2009 , pp. 493-508(16)

Publisher: Future Medicine